Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: have we been bringing owls to Athens?
Ann Oncol. 2019 Dec 1;30(12):1849-1850.
doi: 10.1093/annonc/mdz444.
1 Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breast Center, Hirslanden Klinik St Anna, Lucerne. Electronic address: [email protected].
2 Breast Center, University Hospital of Basel, Basel, Switzerland; Department of Surgery, Memorial Sloan Kettering Cancer Center, Breast Service, New York, USA.
3 Breast Center, University Hospital of Basel, Basel, Switzerland.